You have access
Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
TAKASHI HIGUCHI, NORIHIKO SUGISAWA, KENTARO MIYAKE, HIROMICHI OSHIRO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, ZOEY KLINE, PAIGE BELT, SANT P. CHAWLA, MICHAEL BOUVET, SHREE RAM SINGH, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
Anticancer Research September 2019, 39 (9) 4781-4786; DOI: https://doi.org/10.21873/anticanres.13662